PE01.62LB MyPrEP Decision Support Tool increases PrEP persistence in adolescent girls and young women attending an urban primary health care clinic in South AfricaE-posterBehavioural and social science research
PE01.63LB "…I am here going strong": HIV-positive adolescents' perspectives on the influence of Operation Triple Zero initiative on HIV adherence and viral load suppression in Kisumu, KenyaE-posterBehavioural and social science research
PE02.01 Structure of a CD4 binding site directed antibody in a donor with broadly neutralizing antibodiesE-posterBroadly neutralizing antibodies
PE02.03 Antibody-Antigen Distance of Broadly Neutralizing HIV-1 Antibodies Correlates with Glycan-Shield Coverage of HIV-1 Envelope TrimerE-posterBroadly neutralizing antibodies
PE02.04 Variation in neutralization susceptibility of HIV-1 Indian subtype C to potent and broadly neutralizing monoclonal antibodies (bnAbs) having distinct epitope specificitiesE-posterBroadly neutralizing antibodies
PE02.05 Antibody genetic diversity with large structural variation in a South African populationE-posterBroadly neutralizing antibodies
PE02.06 Founder Env-specific IgM B cell responses during acute HIV-1 infection associate with the development of broadly neutralizing antibodiesE-posterBroadly neutralizing antibodies
PE02.07 IgG3 HIV broadly neutralizing antibodies show improved neutralization potency and phagocytosis compared to IgG1 variantsE-posterBroadly neutralizing antibodies
PE02.08 Defining the mechanism for varied neutralization potency of HIV neutralizing antibodies with identical variable regions but differing isotypeE-posterBroadly neutralizing antibodies
PE02.09 35O22 and VRC44 define a new highly glycan-dependent multidonor class of HIV-1 gp120:gp41 interface-directed bnAbsE-posterBroadly neutralizing antibodies
seek-warrow-warrow-eseek-e241 - 250 of 444 items